Archive for June, 2013« Previous Entries
Sunday, June 30th, 2013
Decades of research has shown that prescribing Altace or other hypertension medications is a viable approach for patients who have a blood pressure equal to or greater than 160/100. However, more patients are being prescribed with powerful medications like Altace despite having milder hypertension.
This practice of prescribing medications on habit and belief may not be [...]
Saturday, June 29th, 2013
Bimatoprost and Latanoprost are both ophthalmic medications, and a study conducted in the United States showed that the former lasted longer without degradation in a patient-use setting. The study was done by John G. Walt from the Global Health Outcomes Strategy & Research, Allergan, Inc.
The stability of ophthalmic drugs stored in multi-dose containers is based [...]
Friday, June 28th, 2013
Brilinta is the brand name for ticagrelor, and it is a new-generation blood thinner that has recently received funding for production in New Zealand. The medication is used for the treatment of acute coronary syndrome or ACS. Heart conditions like ACS are one of the leading causes of death in the country. Men have a [...]
Thursday, June 27th, 2013
According to a recent systematic review, licensed medications like bupropion may be an effective tool in quitting smoking. The study covered several other Cochrane reviews in the past and providers further support for smoking cessation medicines being used around the world.
Currently in the United States, the range of smoking cessation medications licensed for the purpose [...]
Wednesday, June 26th, 2013
A recent consumer update from the FDA talks about the drowsiness caused by allergy medications and how it may make people too drowsy to drive safely. Allergy season has begun in the last few weeks, and the agency has taken this opportunity to warn consumers about taking cetirizine and other anti-allergy medications and driving.
Dr. Jane [...]
Tuesday, June 25th, 2013
A research report on the anti-prostatic hyperplasia or anti-PH market for 2013-2017 was published. In it, it shows that the Tamsulosin (brand name Flomax) is among the top anti-PH drugs in the market for hospital usage. The other dominating drugs include Finasteride, Cernilton, and Doxazosin. Together, they control almost 80 percent off the nationwide anti-PH [...]
Monday, June 24th, 2013
More than 22 million people in the United States suffer from asthma, and a large percentage of this population is also diagnosed with gastro-esophageal reflux disease or GERD. It has therefore become common to see doctors prescribe lansoprazole, a proton pump inhibitor, for people who have poorly controlled asthma. However, a recent study by John [...]
Sunday, June 23rd, 2013
A recent review suggests a link between Proton-pump inhibitors like lansoprazole with commonly acquired pneumonia or CAP. The review was authored by Edward C. Oldfield IV and David A. Johnson. Both are from the Gastroenterology Division of the Department of Medicine, Eastern Virginia Medical School, Norfolk, Virginia.
In the past, several studies have been conducted to [...]
Saturday, June 22nd, 2013
A recent study conducted by the University of Alabama, Birmingham, suggests that hypertension and cardiovascular patients react to non-diuretic therapy as diuretic therapy. Non-diuretic therapy involves the use of an ACE inhibitor like lisinopril with a calcium channel blocker like amlodipine.
The study aimed at determining what type of drug treatment is better for treating and [...]
Friday, June 21st, 2013
According to a recent report published by IMS Health, statins like lovastatin are being prescribed more often while other cholesterol-lowering medications have reduced in their frequency of usage. Statins are already one of the most prescribed drug classes in the United States. The number of statin usage has increased by 17 percent, according to the [...]« Previous Entries